Cohealyx is bioengineered for full-thickness wound management to help physicians achieve definitive closure sooner by preparing wounds for grafting in as few as 5 days.1-3
Listen in as Carmen Flores, MD, describes her experience.
References: 1. ClinicalTrials.gov identifier: NCT06787690. Interim Analysis. Publication in Progress. 2. Akpunonu C, et al. J Surg. 2025;10(07):11337. 3. AVITA Medical. (2026, April 14). AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting [Press release]. https://ir.avitamedical.com/news-releases/news-release-details/avita-medical-announces-positive-interim-results-cohealyxr-study
©2026 AVITA Medical. AVITA Medical®, the AVITA Medical logo, Cohealyx®, the Cohealyx logo, and RECELL® are trademarks of AVITA Medical. All other trademarks are the properties of their respective owners. PRO-2624-v1
Products described on this website are not available in all countries. Regulatory approvals, indications for use, labeling, and product availability vary by jurisdiction. Please consult your local AVITA Medical representative or the applicable Instructions for Use for country-specific information.